12.01.2013 Views

immunology of infectious and parasitic diseases - XXXVII Congress ...

immunology of infectious and parasitic diseases - XXXVII Congress ...

immunology of infectious and parasitic diseases - XXXVII Congress ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

LEISHMANIA CHAGASI RESISTANT TO ANTIMONY IN VIVO AND IN VITRO<br />

DOWN MODULATE MACROPHAGE KILLING MECHANISMS<br />

MICHELI LUIZE BARBOSA SANTOS (1) ; FABRÍCIA ALVISI DE OLIVEIRA (1)<br />

;FLÁVIA MARIA MATOS MELO CAMPOS (1) ; JUCIENE DE MATOS BRAZ (1) ;<br />

PRISCILA LIMA SANTOS (1) ; PAULO DE TARSO GONÇALVES LEOPOLDO (1)<br />

AMÉLIA RIBEIRO DE JESUS (1,2) ; ROQUE PACHECO ALMEIDA (1,2) ; TATIANA<br />

RODRIGUES DE MOURA (1)<br />

(1) Universidade Federal de Sergipe – Aracaju, Brazil; (2) Instituto de<br />

Investigação em Imunologia, São Paulo, Brazil<br />

Introduction: Pentavalent antimonials (Sb V ) have been used to treatment<br />

leishmaniasis for the past 50 years. Although the requirement <strong>of</strong> a functional<br />

cellular immune response for antimony antileishmanial action was previously<br />

reported, the cellular <strong>and</strong> molecular mechanism <strong>of</strong> involved is still unclear. Sb V<br />

is known to reinforce the killing mechanisms <strong>of</strong> macrophages. In the present<br />

study, we evaluated if L. chagasi (Lc) isolated from refractory to antimony<br />

treatment patients has cross-resistance to SbIII <strong>and</strong> NO <strong>and</strong> also modulate<br />

macrophage infection.<br />

Methods <strong>and</strong> Results: Four L. chagasi isolates from antimony treatment<br />

refractory patients <strong>and</strong> two from antimony treatment responsive patients were<br />

used in this study. In vitro susceptibility nitric oxide (NO) was evaluated by<br />

exposing the parasites to different concentrations <strong>of</strong> NaNO2 (NO donor) <strong>and</strong> the<br />

viability was determined by MTT colorimetric method. The Lc isolates from<br />

refractory patients were two times more resistant to NO than those from<br />

patients responsive at NaNO2 8nM (86+9 <strong>and</strong> 46+9, p>0.005, respectively).<br />

Promastigotes were submitted to increasing concentrations <strong>of</strong> antimony<br />

trivalente (Sb III ) <strong>and</strong> the viability was determined by cell count. The Sb III 50%<br />

inhibitory concentration for the isolates from refractory patients was 741+32 <strong>and</strong><br />

for the sensitive patients was 381+100, p>0.01. To evaluate the susceptibility <strong>of</strong><br />

amastigotes to Sb V <strong>and</strong> macrophages killing mechanism, macrophages were<br />

infected in the presence <strong>of</strong> media, LPS/IFN-γ or Sb V , at 24, 48 <strong>and</strong> 72 hours.<br />

Isolates from refractory patients were more infective than isolates from patients<br />

responsive to treatment, independently <strong>of</strong> these stimuli <strong>and</strong> in all times post<br />

infection. Although isolates from refractory patients produced more nitrite than<br />

those from responsive, the rate nitrite/amastigotes was six times lower in the<br />

macrophage infected by isolates from refractory patients.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!